Abilify Maintena 400 mg therapeutic kit contains 400 mg aripiprazole (as monohydrate) per vial. Abilify Maintena 300 mg therapeutic kit contains 300 mg.
ABILIFY MAINTENA, , OTSUKA PHARMACEUTICAL CO LTD, ARIPIPRAZOLE 300 MG / SYR. Previous1Next ABILIFY MAINTENA. ARIPIPRAZOLE 300 MG / VIAL. ABILIFY
Abilify Maintena Syringe information 300 mg. Each vial or dual chamber syringe contains 300 mg of Abilify Maintena Syringe (Aripiprazole) as a lyophilized
$18. . ABILIFY MAINTENA 300 MG SUSER SYR. INTRAMUSCULAR each. Brand. $1,923. . ABILIFY MAINTENA 300 MG SUSPENSION, EXTENDED RELEASE VIAL.
Deficit Hyperactivity Disorder (ADHD). Medications (Non ABILIFY MAINTENA ER 300 MG SYR. . ABILIFY MAINTENA ER 300 MG VL.
Company: OTSUKA PHARMACEUTICAL CO LTD ; , ABILIFY MAINTENA, ARIPIPRAZOLE, 300 MG / VIAL, KIT ; , ABILIFY MAINTENA, ARIPIPRAZOLE, 300 MG / VIAL
Abilify Maintena Syringe information 300 mg. Each vial or dual chamber syringe contains 300 mg of Abilify Maintena Syringe (Aripiprazole) as a lyophilized
Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection. Each vial contains 300 mg aripiprazole. Abilify Maintena 400 mg
ABILIFY MAINTENA, 2,567 patients have been treated with ABILIFY MAINTENA 400 mg/300 and significantly lower relapse rates with ABILIFY
Comments